Quantcast
Viewing all articles
Browse latest Browse all 3347

David Epstein gets $140M for Ottimo's bifunctional take on hot PD-1xVEGF field

David Epstein has retired three times. And he quickly went to work when he got back in the saddle earlier this fall as CEO and chair of Ottimo Pharma, a preclinical biotech trying to take ...

Viewing all articles
Browse latest Browse all 3347

Trending Articles